We have found that the tumor-promoting effects of LONP1 are primarily attributed to metabolic reprogramming, particularly the activation of a metabolic switch from OXPHOS to aerobic glycolysis in PCa cells. This evidence concerns the gene LONP1 and posterior cortical atrophy.